Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Califano

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1997
Impact of chromosome 14q loss on survival in primary head and neck squamous cell carcinomaD J Lee, W M Koch, G Yoo, et al.
Cancer Research|August 15, 1996
High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinomaA L Reed, J Califano, P Cairns, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 12, 2011
NID2 and HOXA9 promoter hypermethylation as biomarkers for prevention and early detection in oral cavity squamous cell carcinoma tissues and salivaR Guerrero-Preston, E Soudry, J Acero, et al.
Oncogene|July 25, 2006
The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formationT J Seng, J S W Low, H Li, et al.
Nature Genetics|October 1, 1995
Frequency of homozygous deletion at p16/CDKN2 in primary human tumoursP Cairns, T J Polascik, Y Eby, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1997
Impact of chromosome 14q loss on survival in primary head and neck squamous cell carcinomaD J Lee, W M Koch, G Yoo, et al.
Cancer Research|August 15, 1996
High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinomaA L Reed, J Califano, P Cairns, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 12, 2011
NID2 and HOXA9 promoter hypermethylation as biomarkers for prevention and early detection in oral cavity squamous cell carcinoma tissues and salivaR Guerrero-Preston, E Soudry, J Acero, et al.
Oncogene|July 25, 2006
The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formationT J Seng, J S W Low, H Li, et al.
Nature Genetics|October 1, 1995
Frequency of homozygous deletion at p16/CDKN2 in primary human tumoursP Cairns, T J Polascik, Y Eby, et al.
Pageof 3